Who can use Daurismo(Glasdegib)?

The specific medical condition the drug is approved to treat.

Who can use Daurismo(Glasdegib)?

DAURISMO is indicated in combination with low-dose cytarabine for the treatment of newly diagnosed acute myeloid leukemia (AML) in adult patients. This use is specifically for individuals who are 75 years of age or older or who have significant comorbidities that preclude the use of intensive induction chemotherapy.

Daurismo(Glasdegib)

DAURISMO is indicated in combination with low-dose cytarabine for the treatment of newly diagnosed acute myeloid leukemia (AML) in adult patients who are ≥75 years of age or who...

CATEGORY NAVIGATION

Departments

Oncology Hematology Immunology Hepatology Endocrinology Pulmonology Neurology Cardiology Gastroenterology Dermatology

Contact Medical Consultant

Global Drug Search

Clinical recruitment

overseas medical treatment

Remote consultation

Note: Our medical consultant will contact you as soon as possible. We promise to strictly protect your privacy.

Click to submit medical consultant

Mailbox:Info@Lucius.La

Welcome To Consult